Type I IFN-mediated enhancement of anti-leukemic cytotoxicity of γδ T cells expanded from peripheral blood cells by stimulation with zoledronate

Carding, 2002, Gammadelta T cells: functional plasticity and heterogeneity, Nat Rev Immunol, 2, 336, 10.1038/nri797 Tanaka, 1995, Natural and synthetic non-peptide antigens recognized by human gamma delta T cells, Nature, 375, 155, 10.1038/375155a0 Bukowski, 1999, Human gamma delta T cells recognize alkylamines derived from microbes, edible plants, and tea: implications for innate immunity, Immunity, 11, 57, 10.1016/S1074-7613(00)80081-3 Kunzmann, 1999, Gamma/delta T-cell stimulation by pamidronate, N Engl J Med, 340, 737, 10.1056/NEJM199903043400914 Chen, 2003, Adaptive immune response of Vgamma2Vdelta2 T cells: a new paradigm, Trends Immunol, 24, 213, 10.1016/S1471-4906(03)00032-2 Kunzmann, 2000, Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma, Blood, 96, 384, 10.1182/blood.V96.2.384 Gober, 2003, Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells, J Exp Med, 197, 163, 10.1084/jem.20021500 Harwood, 1991, In vivo regulation of human leukocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase: increased enzyme protein concentration and catalytic efficiency in human leukemia and lymphoma, J Lipid Res, 32, 1237, 10.1016/S0022-2275(20)41954-6 Asslan, 1999, Epidermal growth factor stimulates 3-hydroxy-3-methylglutaryl-coenzyme A reductase expression via the ErbB-2 pathway in human breast adenocarcinoma cells, Biochem Biophys Res Commun, 260, 699, 10.1006/bbrc.1999.0945 Takahashi, 2003, Cytoplasmic expression of EGFP in dendritic cells transfected with in vitro transcribed mRNA or cellular total RNA extracted from EGFP expressing leukemia cells, Med Oncol, 20, 335, 10.1385/MO:20:4:335 Osman, 2003, Generation of Ag-specific cytotoxic T lymphocytes by DC transfected with in vitro transcribed influenza virus matrix protein (M1) mRNA, Cytotherapy, 5, 161, 10.1080/14653240310001064 Furukawa, 1994, Establishment of a new cell line with the characteristics of a multipotential progenitor from a patient with chronic myelogenous leukemia in early erythroblastic crisis, Leukemia, 8, 171 Narita, 2001, Leukemia blast-induced T-cell anergy demonstrated by leukemia-derived dendritic cells in acute myelogenous leukemia, Exp Hematol, 29, 709, 10.1016/S0301-472X(01)00636-1 Sato, 2005, Cytotoxic effects of gammadelta T cells expanded ex vivo by a third generation bisphosphonate for cancer immunotherapy, Int J Cancer, 116, 94, 10.1002/ijc.20987 Dieli, 2003, Induction of gammadelta T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo, Blood, 102, 2310, 10.1182/blood-2003-05-1655 Sicard, 2001, Synthetic phosphoantigens enhance human Vgamma9Vdelta2 T lymphocytes killing of non-Hodgkin's B lymphoma, Mol Med, 7, 711, 10.1007/BF03401961 Das, 2001, V(2V(2 T-cell receptor-mediated recognition of aminobisphosphonates, Blood, 98, 1616, 10.1182/blood.V98.5.1616 Kabelitz, 2004, Characterization of tumor reactivity of human V gamma 9V delta 2 gamma delta T cells in vitro and in SCID mice in vivo, J Immunol, 173, 6767, 10.4049/jimmunol.173.11.6767 Kato, 2001, Targeting of tumor cells for human gammadelta T cells by nonpeptide antigens, J Immunol, 167, 5092, 10.4049/jimmunol.167.9.5092 Schilbach, 2001, Induction of proliferation and augmented cytotoxicity of gammadelta T lymphocytes by bisphosphonate clodronate, Blood, 97, 2917, 10.1182/blood.V97.9.2917 Bukowski, 2005, Alternative bisphosphonate targets and mechanisms of action, Biochem Biophys Res Commun, 328, 746, 10.1016/j.bbrc.2004.11.075 Kunzmann, 2004, Polyinosinic-polycytidylic acid-mediated stimulation of human gammadelta T cells via CD11c dendritic cell-derived type I interferons, Immunology, 112, 369, 10.1111/j.1365-2567.2004.01908.x Rincon-Orozco, 2005, Activation of Vγ9Vδ2 Tcells by NKG2D, J Immunol, 175, 2144, 10.4049/jimmunol.175.4.2144